Literature DB >> 28315218

Use of Humanized RS-ATL8 Reporter System for Detection of Allergen-Specific IgE Sensitization in Human Food Allergy.

Eman Ali Ali1, Ryosuke Nakamura2, Franco H Falcone3.   

Abstract

Allergen-specific Immunoglobulin E (IgE) determination lies at the heart of diagnosis of sensitization to food and other allergens. In the past few years, reporter systems capable of detecting the presence of allergen-specific IgE have been developed by several labs. These rely on humanized rat basophil leukemia cell lines stably transfected with reporter genes such as firefly luciferase. In this chapter, we describe protocols for the use of the RS-ATL8 cell line (IgE cross-linking-induced luciferase expression; EXiLE) in 96-well and 384-well formats. We also describe optional treatment steps for enveloped virus and complement inactivation.

Entities:  

Keywords:  Allergy; EXiLE; Humanized RBL; IgE; Luciferase; RS-ATL8; Reporter system

Mesh:

Substances:

Year:  2017        PMID: 28315218     DOI: 10.1007/978-1-4939-6925-8_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Are humanized IgE reporter systems potential game changers in serological diagnosis of human parasitic infection?

Authors:  Prema S Prakash; Michael H W Weber; Jaap J van Hellemond; Franco H Falcone
Journal:  Parasitol Res       Date:  2021-11-12       Impact factor: 2.289

2.  Glycation of the Major Milk Allergen β-Lactoglobulin Changes Its Allergenicity by Alterations in Cellular Uptake and Degradation.

Authors:  Marija Perusko; Manon van Roest; Dragana Stanic-Vucinic; Peter J Simons; Raymond H H Pieters; Tanja Cirkovic Velickovic; Joost J Smit
Journal:  Mol Nutr Food Res       Date:  2018-07-29       Impact factor: 5.914

3.  Development of a protein microarray-based diagnostic chip mimicking the skin prick test for allergy diagnosis.

Authors:  Marina Kalli; Andrew Blok; Long Jiang; Nichola Starr; Marcos J C Alcocer; Franco H Falcone
Journal:  Sci Rep       Date:  2020-10-23       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.